Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$14.67 +0.63 (+4.49%)
As of 03/14/2025 04:00 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$14.08
$15.77
50-Day Range
N/A
52-Week Range
$13.64
$24.50
Volume
269,381 shs
Average Volume
367,656 shs
Market Capitalization
$628.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.83
Consensus Rating
Moderate Buy

Company Overview

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Remove Ads
Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

BBNX Stock News Headlines

Your Wealth is Under Attack
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Beta Bionics initiated with an Outperform at Leerink
Beta Bionics initiated with a Buy at BofA
Beta Bionics initiated with a Buy at Ladenburg
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 at the beginning of 2025. Since then, BBNX shares have decreased by 38.4% and is now trading at $14.67.
View the best growth stocks for 2025 here
.

Beta Bionics (BBNX) raised $204 million in an initial public offering on Thursday, January 30th 2025. The company issued 12,000,000 shares at a price of $17.00 per share.

Beta Bionics' quiet period expired on Tuesday, March 11th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. During the company's quiet period, insiders and underwriters that worked on the IPO were prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
3/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$24.83
High Stock Price Target
$30.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+69.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$53.03 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$628.74 million
Optionable
N/A
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 3/16/2025 by MarketBeat.com Staff
From Our Partners